Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.
Vaccination with synthetic peptides representing cytotoxic T lymphocyte (CTL) epitopes can lead to a protective CTL-mediated immunity against tumors or viruses. We now report that vaccination with a CTL epitope derived from the human adenovirus type 5 E1A-region (Ad5E1A234-243), which can serve as a...
I tiakina i:
| I whakaputaina i: | Proc Natl Acad Sci U S A |
|---|---|
| Ngā kaituhi matua: | , , , , |
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
National Academy of Sciences
1996
|
| Ngā marau: | |
| Urunga tuihono: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC38838/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8755566/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.15.7855 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|